Comparison of Up-to-Date Status Between Study Groups, at Baseline and at Follow-up, According to Intent-to-Treat Analysis Among All Women
| Unadjusted Comparison | Adjusted Comparison* | |||||
|---|---|---|---|---|---|---|
| Screening | PCM No. (%) Up-to-Date | AMOP No. (%) Up-to-Date | OR (95% CI) | P Value | OR (95% CI) | P Value |
| PCM = prevention care management; AMOP = Affinity Mammography Outreach Program (the comparison group); OR = odds ratio; CI = confidence interval. | ||||||
| * Baseline breast and cervical comparisons are adjusted for age (40 to 49 years, 50 years and older); there is no adjusted colorectal baseline comparison because this analysis included only women aged 50 years and older. Follow-up comparisons are adjusted for age (breast and cervical) and for baseline screening status (all 3 screenings). | ||||||
| † Smaller n values for colorectal screening reflect the subset of the study population who were eligible for colorectal cancer screening (ie, aged 50 years and older). | ||||||
| ‡P≤.05. | ||||||
| Breast | (n=663) | (n=653) | ||||
| Baseline | 219 (33) | 217 (33) | 0.99 (0.78–1.26) | .94 | 0.97 (0.75–1.27) | .85 |
| Follow-up | 343 (52) | 326 (50) | 1.08 (0.86–1.34) | .51 | 1.16 (0.86–1.57) | .33 |
| Cervical | (n=663) | (n=653) | ||||
| Baseline | 344 (52) | 333 (51) | 1.04 (0.83–1.29) | .75 | 1.03 (0.83–1.29) | .76 |
| Follow-up | 423 (64) | 403 (62) | 1.09 (0.87–1.38) | .43 | 1.18 (0.82–1.70) | .38 |
| Colorectal† | (n=317) | (n=309) | ||||
| Baseline | 56 (18) | 48 (16) | 1.17 (0.75–1.82) | .47 | – | – |
| Follow-up | 103 (32) | 78 (25) | 1.43 (0.99–2.05) | .05 | 1.69‡ (1.03–2.77) | .04 |